[ad_1]
Original title: Announcement on resolutions of the First Extraordinary General Meeting of Shareholders of Cansino Biotech Co., Ltd. in 2020
Stock Code: 688185 Stock Abbreviation: Cansino Ad Number: 2020-007
Important content reminder:
● Are there any resolutions rejected at this meeting? None
1. Meeting and attendance
(1) Date of the general shareholders’ meeting: October 9, 2020
(2) Place of the shareholders’ meeting: Conference room on the 11th floor, CITIC Securities Building, No. 48 Liangmaqiao Road, Chaoyang District, Beijing, China
(3) The situation of ordinary shareholders, shareholders with special voting rights, preferred shareholders with restored voting rights and the number of voting rights held at the meeting:
(4) If the voting method complies with the provisions of the “Public Limited Companies Law” and the bylaws of the company, chairmanship of the meeting, etc.
This meeting was called by the company’s board of directors and chaired by Dr. Xuefeng YU (Yu Xuefeng), chairman of the board. The meeting uses a combination of on-site and online voting to vote. The calling, summoning and voting procedures for this meeting comply with the “Corporations Law”, the “Securities Law” and the “Bylaws”.
(5) Attendance of directors, supervisors and secretary of the board of the company
1. There are 12 directors of the company, and 12 of them attended through combined communication methods on site;
2. There are 3 regular supervisors of the company and 3 people served by combined communication methods on site;
3. The secretary of the board of directors of the company attended the meeting, the meeting was attended by executives of the company and witness lawyers as delegates without the right to vote.
2. Review of the proposal
(1) Non-cumulative voting proposals
1. Name of the proposal: “Proposal on modifying the use of funds obtained in H shares”
Deliberation results: approved
Voting situation:
2. Name of the proposal: “Proposal to permanently supplement the working capital with part of the funds raised in excess”
Deliberation results: approved
Voting situation:
(2) If it is about important questions, the voting status of the shareholders below 5% will be explained.
(3) Explanation of the relevant situation of the vote on the motion.
1. Proposals 1 and 2 are ordinary resolutions, which have been approved by more than half of the total number of valid shares with voting rights held by the shareholders or representatives of the shareholders attending the meeting.
2. Proposals 1 and 2 were accounted for separately for small and medium investors.
3. Lawyers’ witnesses
1. Law firm witnessed at this shareholders meeting: Beijing Tianyuan Law Firm
Lawyers: Zhen Yueneng, Liu Juan
2. The lawyer is a witness to the conclusion:
The procedures for convening and convening the company’s shareholders ‘meeting comply with the laws, administrative regulations, the “Regulations for the General Shareholders’ Meeting” and the “Bylaws”; the qualifications of the personnel attending the face-to-face meeting of the shareholders’ meeting and the qualifications of the convener are legal and valid; current shareholders’ meeting Voting procedures and voting results are legal and valid.
Board of Directors of Cansino Biological Co., Ltd.
October 12, 2020
● Archive documents
(1) The agreements of the general meeting of shareholders signed and confirmed by the participating directors and registrars and stamped with the seal of the board of directors;
(2) Legal opinion signed and stamped with official seal by the witness of the director of the law firm;
(3) Other documents required by the Exchange.
